These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4678619)

  • 1. The effect of propranolol and alprenolol on spontaneous motility of mice.
    Fabian HE; Izguierdo JA
    Arzneimittelforschung; 1972 Sep; 22(9):1553. PubMed ID: 4678619
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE; Izquierdo JA
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers.
    Offerhaus L; van Zwieten PA
    Cardiovasc Res; 1974 Jul; 8(4):488-95. PubMed ID: 4426059
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect propranolol, alprenolol and practolol on the vibrinolytic and factor VIII responses to adrenaline and salbutamol in man.
    Gader AM; Da Costa J; Cash JD
    Thromb Res; 1974 Jan; 4(1):25-33. PubMed ID: 4829668
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dl-propranolol and l-and d-alprenolol on arterial pressure in awake or anesthesized, normo- or hypertensive rats].
    Davy M; Cohen Y; Wepierre J
    C R Seances Soc Biol Fil; 1975; 169(2):306-12. PubMed ID: 126761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprenolol and propranolol in the treatment of hypertension: a comparative study.
    Somer T; Luomanmäki K; Frick MH
    Acta Med Scand Suppl; 1974; 554():33-7. PubMed ID: 4593671
    [No Abstract]   [Full Text] [Related]  

  • 7. The adrenergic neuron blocking activity of propranolol and alprenolol.
    Del Río J; López De Ceballos M
    Arch Farmacol Toxicol; 1975 Aug; 1(2):125-36. PubMed ID: 1230027
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of isoprenaline, propranolol and alprenolol on the glycogen phosphorylase activity and glycogen level of the heart of neonate and adult rats.
    Brus R
    Pol J Pharmacol Pharm; 1973; 25(5):423-8. PubMed ID: 4777345
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Effects of propranolol and alprenolol on rat atrial and ventricular muscles.
    Nagata M; Sugimoto J
    Jpn J Pharmacol; 1974; 24(0):s:64. PubMed ID: 4545619
    [No Abstract]   [Full Text] [Related]  

  • 10. Some metabolic effects of metipranolol, propranolol, alprenolol, oxprenolol, and practolol in rats.
    Siblíková O; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(5-6):259-70. PubMed ID: 6126105
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous motor activity in rats given repeatedly beta-sympatholytics, propranolol and trimepranol.
    Tikal K; Hvizdosová J; Pavlovicová E
    Act Nerv Super (Praha); 1980 Mar; 22(1):71-2. PubMed ID: 6104410
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effect of dihydroergocristine, phenoxybenzamine and propranolol on the hypermotility induced by low doses of ethyl alcohol in mice.
    Boada JN; Feria M; Serrano M; Darias V
    Arch Farmacol Toxicol; 1979 Aug; 5(2):117-22. PubMed ID: 119498
    [No Abstract]   [Full Text] [Related]  

  • 14. Central action of drugs affecting beta-adrenergic receptor. II. The central action of intraventricularly applicated propranolol in rats.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):297-304. PubMed ID: 4859243
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of D- and L-alprenolol on the isolated rat heart.
    Brus R; Drzewiecki J
    Pol J Pharmacol Pharm; 1973; 25(5):429-34. PubMed ID: 4777346
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of d- and 1- propranolol on spontaneous motility and retention in male mice.
    Izquierdo JA; Fabian HE; Chemerinski E
    Acta Physiol Lat Am; 1974; 24(6):669-70. PubMed ID: 4469407
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of nifedipine, a calcium channel inhibitor, on sedation produced by reserpine, clonidine and propranolol in mice.
    Desai MK; Dikshit RK; Mansuri SM; Shah UH
    Indian J Exp Biol; 1994 May; 32(5):314-7. PubMed ID: 7927523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule.
    Kinney GG; Griffith JC; Hudzik TJ
    Behav Pharmacol; 1998 Jul; 9(4):309-18. PubMed ID: 10065919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic interaction of ethanol and alprenolol in isolated liver cells.
    Grundin R
    Acta Pharmacol Toxicol (Copenh); 1975 Sep; 37(3):185-200. PubMed ID: 1242604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antagonistic effect of beta-sympatholytics on methamphetamine-induced changes in the function and metabolism in brain].
    Estler CJ; Ammon HP
    Arzneimittelforschung; 1970 Jul; 20(7):908-9. PubMed ID: 5536056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.